The US Food and Drug Administration has granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday.
The treatment received accelerated approval for triple-negative breast cancer that is locally advanced or metastatic, that cannot be surgically removed and whose cells include a protein called PD-L1. It comprises a combination of immunotherapy and chemotherapy: Tecentriq and Abraxane, respectively.
Chemotherapy is also needed to"rough up" the exterior of the cancer cell, Schmid explained. That allows the newly revved-up immune system to recognize and attack the invader."We are using chemotherapy to tear away the tumor's 'immune-protective cloak,' to expose it," Schmid said,"enabling people's own immune system to get at it."Norton said in October that"I think the expectation is, this will change the standard of care.
Maybe they should pick cancers with a higher mortality rate like GBM, pancreatic... GBM has a 5% survival rate at 5 years...
Hard to trust the FDA... They assisted in creating an opioid epidemic...
Ok but can we get a better less painful breast screening? The smash'em up titty twisting is getting fucking old. How about we put men's nutsac in for cancer screening? I bet then they'd find a less painful way to screen?
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: Forbes - 🏆 394. / 53 Read more »